IL139589A0 - Use of cyclosporins in the treatment of inflammatory autoimmune diseases - Google Patents
Use of cyclosporins in the treatment of inflammatory autoimmune diseasesInfo
- Publication number
- IL139589A0 IL139589A0 IL13958999A IL13958999A IL139589A0 IL 139589 A0 IL139589 A0 IL 139589A0 IL 13958999 A IL13958999 A IL 13958999A IL 13958999 A IL13958999 A IL 13958999A IL 139589 A0 IL139589 A0 IL 139589A0
- Authority
- IL
- Israel
- Prior art keywords
- cyclosporins
- treatment
- autoimmune diseases
- inflammatory autoimmune
- inflammatory
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9811854.0A GB9811854D0 (en) | 1998-06-02 | 1998-06-02 | Organic compounds |
| PCT/EP1999/003770 WO1999062540A1 (en) | 1998-06-02 | 1999-05-31 | Use of cyclosporins in the treatment of inflammatory autoimmune diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL139589A0 true IL139589A0 (en) | 2002-02-10 |
Family
ID=10833083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13958999A IL139589A0 (en) | 1998-06-02 | 1999-05-31 | Use of cyclosporins in the treatment of inflammatory autoimmune diseases |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1082130A1 (no) |
| JP (2) | JP4523154B2 (no) |
| KR (1) | KR20010043969A (no) |
| CN (1) | CN1304315A (no) |
| AU (1) | AU750422B2 (no) |
| BR (1) | BR9910860A (no) |
| CA (1) | CA2333315A1 (no) |
| GB (1) | GB9811854D0 (no) |
| HU (1) | HUP0102142A3 (no) |
| ID (1) | ID27576A (no) |
| IL (1) | IL139589A0 (no) |
| NO (1) | NO20006113L (no) |
| PL (1) | PL344451A1 (no) |
| SK (1) | SK18142000A3 (no) |
| TW (2) | TWI250022B (no) |
| WO (1) | WO1999062540A1 (no) |
| ZA (1) | ZA200006464B (no) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1223971E (pt) | 1999-10-27 | 2005-10-31 | Alexandra Lucas | Composicoes e metodos para prevencao e tratamento da rejeicao de transplante |
| AU2001291579B2 (en) * | 2000-09-29 | 2006-08-31 | Viron Therapeutics Inc. | Use of serp- 1 in combination with an immunosuppressant for influencing inflammatory and immune reactions |
| GB0320638D0 (en) | 2003-09-03 | 2003-10-01 | Novartis Ag | Organic compounds |
| JP2007532507A (ja) * | 2004-04-08 | 2007-11-15 | ノバルティス アクチエンゲゼルシャフト | 脳虚血ならびに脳および脊髄傷害の処置のためのサイクロスポリンの使用 |
| CA2573207C (en) | 2004-07-14 | 2013-04-16 | Novartis Ag | Use of a combination of cyclosporin and pegylated interferons for treating hepatitis c (hcv) |
| JP4892486B2 (ja) * | 2004-10-01 | 2012-03-07 | デビオファーム ソシエテ アノニム | Ｃ型肝炎感染の治療のための［ｄ−ｍｅａｌａ］３−［ｅｔｖａｌ］４−シクロスポリンの使用、及び当該［ｄ−ｍｅａｌａ］３−［ｅｔｖａｌ］４−シクロスポリンを含む医薬組成物 |
| US7285530B2 (en) | 2004-10-21 | 2007-10-23 | Viron Therapeutics, Inc. | Use of SERP-1 as an antiplatelet agent |
| CN101076350A (zh) * | 2004-12-23 | 2007-11-21 | 诺瓦提斯公司 | 用于hcv治疗的组合物 |
| JP2008525458A (ja) * | 2004-12-23 | 2008-07-17 | ノバルティス アクチエンゲゼルシャフト | フラビウイルス科処置用化合物 |
| EP1893211B1 (en) | 2005-06-17 | 2011-09-14 | Novartis AG | Use of sanglifehrin in hcv |
| JP2007112775A (ja) * | 2005-10-24 | 2007-05-10 | Hamamatsu Univ School Of Medicine | サイトメガロウイルス感染の処置におけるシクロスポリン類の使用 |
| US20090306033A1 (en) * | 2008-06-06 | 2009-12-10 | Keqiang Li | Novel cyclic peptides |
| JP5820722B2 (ja) * | 2008-06-06 | 2015-11-24 | スシネキス インク | シクロスポリン類似体及びｈｃｖ感染の治療におけるその使用 |
| EP2376524B1 (en) | 2008-12-31 | 2017-03-15 | Cypralis Limited | Derivatives of cyclosporin a |
| WO2011070364A1 (en) * | 2009-12-09 | 2011-06-16 | Scynexis, Inc. | Novel cyclic peptides |
| EP2900684A2 (en) | 2012-09-29 | 2015-08-05 | Novartis AG | Cyclic peptides and use as medicines |
| EP2908841A4 (en) * | 2012-10-19 | 2016-05-25 | Scynexis Inc | NEW ANTIVIRAL MACROCYCLES |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ280909B6 (cs) * | 1990-11-02 | 1996-05-15 | Novartis Ag | Nové cyklosporiny |
| US6124453A (en) * | 1995-07-04 | 2000-09-26 | Novartis Ag | Macrolides |
| AR006514A1 (es) * | 1995-07-04 | 1999-09-08 | Sandoz Ag | Un macrolido, sus usos, un proceso para producirlo, un aislado biologicamente puro capaz de producirlo, y una composicion farmaceutica quelo comprende |
| CZ288631B6 (cs) * | 1996-01-18 | 2001-08-15 | Galena, A. S. | Léčivé přípravky s obsahem cyklosporinu |
| CZ288739B6 (cs) * | 1996-08-01 | 2001-08-15 | Galena, A. S. | Cyklosporin obsahující léčivé přípravky |
-
1998
- 1998-06-02 GB GBGB9811854.0A patent/GB9811854D0/en not_active Ceased
-
1999
- 1999-05-31 EP EP99926489A patent/EP1082130A1/en not_active Withdrawn
- 1999-05-31 CN CN99806904A patent/CN1304315A/zh active Pending
- 1999-05-31 KR KR1020007013585A patent/KR20010043969A/ko not_active Application Discontinuation
- 1999-05-31 PL PL99344451A patent/PL344451A1/xx not_active Application Discontinuation
- 1999-05-31 IL IL13958999A patent/IL139589A0/xx unknown
- 1999-05-31 CA CA002333315A patent/CA2333315A1/en not_active Abandoned
- 1999-05-31 AU AU43724/99A patent/AU750422B2/en not_active Ceased
- 1999-05-31 WO PCT/EP1999/003770 patent/WO1999062540A1/en not_active Application Discontinuation
- 1999-05-31 ID IDW20002433A patent/ID27576A/id unknown
- 1999-05-31 JP JP2000551796A patent/JP4523154B2/ja not_active Expired - Fee Related
- 1999-05-31 HU HU0102142A patent/HUP0102142A3/hu unknown
- 1999-05-31 BR BR9910860-7A patent/BR9910860A/pt not_active IP Right Cessation
- 1999-05-31 SK SK1814-2000A patent/SK18142000A3/sk unknown
- 1999-06-01 TW TW088109078A patent/TWI250022B/zh not_active IP Right Cessation
- 1999-06-01 TW TW094110378A patent/TWI250021B/zh not_active IP Right Cessation
-
2000
- 2000-11-09 ZA ZA200006464A patent/ZA200006464B/en unknown
- 2000-12-01 NO NO20006113A patent/NO20006113L/no not_active Application Discontinuation
-
2009
- 2009-11-04 JP JP2009252882A patent/JP2010059177A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0102142A2 (hu) | 2001-11-28 |
| KR20010043969A (ko) | 2001-05-25 |
| JP4523154B2 (ja) | 2010-08-11 |
| WO1999062540A1 (en) | 1999-12-09 |
| EP1082130A1 (en) | 2001-03-14 |
| NO20006113D0 (no) | 2000-12-01 |
| GB9811854D0 (en) | 1998-07-29 |
| TW200522975A (en) | 2005-07-16 |
| SK18142000A3 (sk) | 2001-06-11 |
| BR9910860A (pt) | 2001-03-06 |
| HUP0102142A3 (en) | 2001-12-28 |
| ID27576A (id) | 2001-04-12 |
| TWI250021B (en) | 2006-03-01 |
| AU750422B2 (en) | 2002-07-18 |
| AU4372499A (en) | 1999-12-20 |
| TWI250022B (en) | 2006-03-01 |
| CN1304315A (zh) | 2001-07-18 |
| NO20006113L (no) | 2001-01-25 |
| CA2333315A1 (en) | 1999-12-09 |
| JP2002516873A (ja) | 2002-06-11 |
| JP2010059177A (ja) | 2010-03-18 |
| ZA200006464B (en) | 2002-03-11 |
| PL344451A1 (en) | 2001-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA983452B (en) | Substituted pyrrolopyridines useful in the treatment of inflammatory diseases. | |
| IL132318A0 (en) | Substituted imidazoles useful in the treatment of inflammatory diseases | |
| IL142908A0 (en) | Compounds useful in the treatment of inflammatory diseases | |
| IL133766A0 (en) | 2-substituted imidazoles useful in the treatment of inflammatory diseases | |
| HUP0102142A3 (en) | Use of cyclosporins in the treatment of inflammatory autoimmune diseases | |
| PL362984A1 (en) | Compounds useful in the treatment of inflammatory diseases | |
| IL144981A0 (en) | Treatment of autoimmune disease | |
| IL131025A0 (en) | Treatment of autoimmune disease using tolerization in combination with methotrexate | |
| IL148401A0 (en) | Hsp70-derived peptides and uses thereof in the diagnosis and treatment of autoimmune diseases | |
| HK1038601A1 (en) | Human body cleaner. | |
| ZA984174B (en) | Novel triptolide derivatives useful in the treatment of autoimmune diseases | |
| PL362350A1 (en) | Chemokine mutants in the treatment of multiple sclerosis | |
| HK1025954A1 (en) | Triptolide derivatives useful in the treatment of autoimmune diseases | |
| EP1079764A4 (en) | TREATMENT OF SEXUALITY DISORDERS IN CERTAIN GROUPS OF PATIENTS | |
| IL129024A0 (en) | Use of proteins as agent against autoimmune diseases | |
| GB9927757D0 (en) | Treatment of autoimmune diseases | |
| IL129460A0 (en) | Use of lofexidine in the treatment of behavioral disorders | |
| HUP0200354A3 (en) | Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases | |
| HUP0200552A2 (en) | Use of apoptosis inducing agents in the treatment of (auto)immune diseases | |
| IL140825A0 (en) | Peptides for use in immunotherapy of autoimmune diseases | |
| GB9603657D0 (en) | Improvements in the treatment of vaginal infections | |
| SI0983275T1 (en) | Novel triptolide derivatives useful in the treatment of autoimmune diseases | |
| AU2002300624A1 (en) | Substituted imidazoles useful in the treatment of inflammatory diseases | |
| SI0966447T1 (en) | Small molecules useful in the treatment of inflammatory disease | |
| SI1011649T1 (en) | Use of endipalene in the treatment of psoriasis |